FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2334146779> ?p ?o ?g. }

• W2334146779 endingPage "2202" @default.
• W2334146779 startingPage "2194" @default.
• W2334146779 abstract "In Brief Background It is unclear whether all donor-specific antibodies (DSA) can cause chronic antibody-mediated rejection (AMR). Subclinical stage before manifestation of renal dysfunction may be a critical period for reversing AMR. The aim of our study was to identify factors related to the development of subclinical AMR and to clarify the characteristics of de novo DSA. Methods Eight hundred ninety-nine renal transplants were screened for HLA antibody. De novo DSA were detected in 95 patients. Forty-three patients without renal dysfunction who underwent renal biopsies were enrolled in this study. Eighteen patients (41.9%) were diagnosed with biopsy-proven subclinical AMR and treated with plasmapheresis and rituximab-based therapy, whereas 25 showed no findings of AMR. Results Significant subclinical AMR-related factors were younger recipients, history of acute T cell–mediated rejection and DSA class II, especially DR-associated DSA. Mean fluorescence intensity (MFI) values of DR-DSA were significantly higher, whereas DQ-DSA was not different between subclinical AMR and no AMR. The ΔMFI (>50%), DSA-MFI values greater than 3000, and C1q binding DSA were also significant subclinical AMR-related factors (P < 0.05). Among 18 patients treated for subclinical AMR, 8 patients (44.4%) obtained over 50% reduction of DSA-MFI and/or improvement or no deterioration of pathological findings. In contrast, 25 patients without subclinical AMR did not show renal dysfunction clinically. Moreover, all of the 8 patients with rebiopsy after 2 years continued to demonstrate no AMR. Conclusions About 40% of patients with de novo DSA demonstrated biopsy-proven subclinical AMR, leading to progressive graft injury. To validate the intervention and treatment for de novo DSA-positive patients without renal dysfunction, further study is necessary. The authors describe a population of kidney transplant recipients with de novo DSA, no deterioration of renal function, and a concomitant kidney biopsy. They report on the factors associated with the occurrence of subclinical antibody-mediated rejection." @default.
• W2334146779 created "2016-06-24" @default.
• W2334146779 creator A5011931993 @default.
• W2334146779 creator A5031345157 @default.
• W2334146779 creator A5040905965 @default.
• W2334146779 creator A5043607146 @default.
• W2334146779 creator A5044832513 @default.
• W2334146779 creator A5058063800 @default.
• W2334146779 creator A5082539982 @default.
• W2334146779 creator A5084593362 @default.
• W2334146779 creator A5087878084 @default.
• W2334146779 creator A5088108322 @default.
• W2334146779 creator A5090820042 @default.
• W2334146779 date "2016-10-01" @default.
• W2334146779 modified "2023-10-13" @default.
• W2334146779 title "De Novo Anti-HLA DSA Characteristics and Subclinical Antibody-Mediated Kidney Allograft Injury" @default.
• W2334146779 cites W1486598251 @default.
• W2334146779 cites W1499906725 @default.
• W2334146779 cites W1505723685 @default.
• W2334146779 cites W1527097930 @default.
• W2334146779 cites W1579460874 @default.
• W2334146779 cites W1737600104 @default.
• W2334146779 cites W1867083735 @default.
• W2334146779 cites W1977262904 @default.
• W2334146779 cites W1981540014 @default.
• W2334146779 cites W1987999831 @default.
• W2334146779 cites W1994002700 @default.
• W2334146779 cites W1996635899 @default.
• W2334146779 cites W1996853835 @default.
• W2334146779 cites W1997464846 @default.
• W2334146779 cites W2021832667 @default.
• W2334146779 cites W2036572535 @default.
• W2334146779 cites W2055946217 @default.
• W2334146779 cites W2065601715 @default.
• W2334146779 cites W2078413135 @default.
• W2334146779 cites W2080702800 @default.
• W2334146779 cites W2092706820 @default.
• W2334146779 cites W2115660072 @default.
• W2334146779 cites W2122930177 @default.
• W2334146779 cites W2127001878 @default.
• W2334146779 cites W2148223163 @default.
• W2334146779 cites W2163559860 @default.
• W2334146779 cites W2333121623 @default.
• W2334146779 cites W2335513291 @default.
• W2334146779 doi "https://doi.org/10.1097/tp.0000000000001012" @default.
• W2334146779 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26636737" @default.
• W2334146779 hasPublicationYear "2016" @default.
• W2334146779 type Work @default.
• W2334146779 sameAs 2334146779 @default.
• W2334146779 citedByCount "66" @default.
• W2334146779 countsByYear W23341467792016 @default.
• W2334146779 countsByYear W23341467792017 @default.
• W2334146779 countsByYear W23341467792018 @default.
• W2334146779 countsByYear W23341467792019 @default.
• W2334146779 countsByYear W23341467792020 @default.
• W2334146779 countsByYear W23341467792021 @default.
• W2334146779 countsByYear W23341467792022 @default.
• W2334146779 countsByYear W23341467792023 @default.
• W2334146779 crossrefType "journal-article" @default.
• W2334146779 hasAuthorship W2334146779A5011931993 @default.
• W2334146779 hasAuthorship W2334146779A5031345157 @default.
• W2334146779 hasAuthorship W2334146779A5040905965 @default.
• W2334146779 hasAuthorship W2334146779A5043607146 @default.
• W2334146779 hasAuthorship W2334146779A5044832513 @default.
• W2334146779 hasAuthorship W2334146779A5058063800 @default.
• W2334146779 hasAuthorship W2334146779A5082539982 @default.
• W2334146779 hasAuthorship W2334146779A5084593362 @default.
• W2334146779 hasAuthorship W2334146779A5087878084 @default.
• W2334146779 hasAuthorship W2334146779A5088108322 @default.
• W2334146779 hasAuthorship W2334146779A5090820042 @default.
• W2334146779 hasConcept C113280763 @default.
• W2334146779 hasConcept C126322002 @default.
• W2334146779 hasConcept C126894567 @default.
• W2334146779 hasConcept C159654299 @default.
• W2334146779 hasConcept C203014093 @default.
• W2334146779 hasConcept C2775934546 @default.
• W2334146779 hasConcept C2778842783 @default.
• W2334146779 hasConcept C2780091579 @default.
• W2334146779 hasConcept C71924100 @default.
• W2334146779 hasConcept C90924648 @default.
• W2334146779 hasConceptScore W2334146779C113280763 @default.
• W2334146779 hasConceptScore W2334146779C126322002 @default.
• W2334146779 hasConceptScore W2334146779C126894567 @default.
• W2334146779 hasConceptScore W2334146779C159654299 @default.
• W2334146779 hasConceptScore W2334146779C203014093 @default.
• W2334146779 hasConceptScore W2334146779C2775934546 @default.
• W2334146779 hasConceptScore W2334146779C2778842783 @default.
• W2334146779 hasConceptScore W2334146779C2780091579 @default.
• W2334146779 hasConceptScore W2334146779C71924100 @default.
• W2334146779 hasConceptScore W2334146779C90924648 @default.
• W2334146779 hasIssue "10" @default.
• W2334146779 hasLocation W23341467791 @default.
• W2334146779 hasLocation W23341467792 @default.
• W2334146779 hasOpenAccess W2334146779 @default.
• W2334146779 hasPrimaryLocation W23341467791 @default.
• W2334146779 hasRelatedWork W1970709107 @default.
• W2334146779 hasRelatedWork W1986678613 @default.
• W2334146779 hasRelatedWork W1996680438 @default.

• next